<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Shirehampton Group Practice</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Shirehampton Group Practice is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0603020F0&amp;denomIds=6.3.2&amp;selectedTab=summary">Cortisone acetate</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Use of corticosteroids</td>
      <td>586</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>40.16</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAHgUlEQVR4nO3df4wcZR3H8fdcC+WiQrEaECE8aDRqNICJShHQiliSQSttgvFXIIrEihIDJn0U+eHRP55KiJhQoxWrttpEEBKLT2r5UaCQC8ZI1Ggk0pDxRzUSW2qk1pTi4x/PA6zbvbud3ZnZY+fzSiZ3uzc73+e53Ofm2ZlnZrMQAiLSDhOjboCINEeBF2kRBV6kRRR4kRZR4EVaRIEXaREFXqRFFHiRFlHgRVpEgRdpEQVepGlZNrL57Aq8SAOM9RuM9aeMuh2ZLp4RqZex/gTgMeA3wLuLdRc8QwjZKNqycBRFRVrmPGAjcAywZpQNUeBF6rcc2Aw8DPxilA3Re3iRGhnrJ4BzgJ2Fy/8FfCI9/9JRtEeBF6nX6cBjhcv3AxQun07P3zSKxijwIvVaDmzv8fypxvoVTTdGgRep13Lg7h7Pfwy42Vh/fJONUeBFamKsfxlwCvF03P8pXL4LWAt811jf2Ck6BV6kPsuABwqXzzTZZSPwH+DyphqkwIvU5330fv8OQPpH8CngSmP9m5pokAIvUp/zgHtmW6Fw+T+A1cAPjPWL6m6QAi9SA2P9a4D9hcufnGvdwuXbgYeAG+pulwIvUo9Zh/M9WOB8Y/2ymtoDKPAidZnp/HtPhcsPAB8Hvl3nVXUKvEjFjPVHAG8Hpudat1Ph8l8DVwE7jPWr07TcSinwIl2M9ccZ628aInDvAB4tXH6w7AsLl/8EOIN4wO9uY/3JA7ahJwVepEO6qOWnwArgAwNuZqbZdX0pXP53YBXxPP2DxvpLq5qco8CLJGkofjtwJ/Ah4NoBg1b2gN1hCpeHwuVbgKXEfzzbjPUnDrNNUOBFAEjB3gA8AbjC5b8E/gpcUHI7S4BXAI9X0a7C5X8jjja2AA8b6y8ZZm+vwItEU8Bi4IqOqbA3UH4vfy5w7yzTaUtLe/tNwDuBi4C70m2zSlPgpfWM9Z8mznv/SOHyZ597vnD5z4E9wPklNlfqdFwZhct3AznxLce0sX6bsf5HZbahwEurGes/CHwWWJHOhXebos+9fFrnXGBHta18QdrbbwTeCnwJWF/m9bqnnbSWsf5M4p1n3lO4fE+vdQqXTxvrnyadJptjk28Edhcu31dtS3u2ay+wt+zrtIeXVjLWvwH4IbCqcPkf51h9Criuj718bcP5qijw0jrG+lcBW4FLC5f/aq71C5c/BBwkvs+fzVDn35ugwEurGOuPBjxwfeHy+0q8dAq4dpbtHgW8hRHfhnouCry0hrF+ErgD2JImtZTxALDAWP+uGX5+NjDdeZR/PlLgpRXSMP5+4BEGuEV0Oq/+FWbeyw89u64JCryMPWP96cBOYH3h8muGmBRzHzBprD+rx8/m/ft3UOBlzBnrVxKH8RcXLt88zLbSP4op4JquGicACwuX/2mY7TdBgZexZKzPjPVXE4fgyzo+8WVY24FjjfVndDzXzzn6eUGBl7GTjphvJt6E4qw+zrP3bYa9/ItiOA8KvIyZ9Eku9wO7gZWFy5+uoYwHjjPWvy3dJONs4MEa6lQuC6Gyi3pERspYfxrxeva1hcu/X3OtFcAniUfu1xUuf2/fL86yQAiNfdpMJ+3hZSyki2DuBC6pO+zJVuAkYA0vkuE81LCHN9Zb4nXFi4Fjur4GYB/wzzm+HgKOAiY7ll6PJ4gf1XOg4+uBHo8PAUd0LUf2eDyR1j0IPNOxdD8+lNZdkJaFHd93LhPAf4Fnu5ZDPZ4bl6HWAuLv8rnf70zfZ7zwuz04y/cLgJd3LEt6PD4a+DNwUeHyov4uRsb6VcCPgdPSDSj7M8I9PCGEShfgsqq3OR9rqq/jWXPc+1rHkP6yGrY5H2uOqq76Op51G6mp9/AiLaLAi7RIHYHfUMM252PNUdVVX8ezbiM1dR5epEU0pBdpkVI3scyy7BzgTODJEMLGLMtWAq8FdgG/Az4KPAXcAqxNL7sauAI4FtgUQthVtpFD1P0W8FtgQwjh3zXV/B5wM/DNEMIjWZZdR5wnsC6E8FSNfe2uexuwM4RwS401txLvi358COHzDfa1u24Tfd0EXAycFEK4ssG+dtcduK+9lN3DLw0hOOCV6fHrQgg3Aq8n3i97LbAIOBW4B7g3fX9k+tn7B2znoHX3AC9hsEktfdUMIewjho8sy5YAfwFuZe77n1VWN9kDTGZZNsiEjn5rPpHW299wX5+vm9Zroq97iWFc0nBfn6+b1humr4cpG/ju4PQbpFBi3crqhhDWED8YsP95zkPWrMCgfV0N/AF4c501syy7kHhxShUGqttUX0MIdxFvnFHF7dxL182ybNGQfT1MqYN2aViylHg/7EeBk4nDkseB3wMfJg5L1hM/pgfgy8Qh/WJg8xBD+kHqXkWc7+xCCLtrqvkN4GvE6aBfIL6VmAS+OsTQr2zd64HPAK8G1oQQ9h+24Wpq7gBuBH4GfJ14iWgTfe2s+x3iB0fU3ddtxE9wPRH4HPHvqYm+dtb9InD5oH3t2Q4dpRdpDx2lF2kRBV6kRRR4kRZR4EVaRIEXaREFXqRFFHiRFlHgRVpEgRdpEQVepEUUeJEW+R844RulqMViOgAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0603020F0AAAHAH&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Cortisone 25mg tablets : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=100101040&amp;denomIds=10.1.1&amp;selectedTab=summary">Tenoxicam</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>1084</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>11.60</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=100101040BBAAAA&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Mobiflex 20mg tablets : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0205040M0&amp;denomIds=2.5.4&amp;selectedTab=summary">Phenoxybenzamine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Alpha-adrenoceptor blocking drugs</td>
      <td>387</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>10.93</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0205040M0AAACAC&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Phenoxybenzamine 10mg capsules : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0601023AC&amp;denomIds=6.1.2&amp;selectedTab=summary">Saxagliptin</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>164</td>
      <td>Other antidiabetic drugs</td>
      <td>916</td>
      <td>0.18</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>6.81</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0601023ACAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Saxagliptin 5mg tablets : 140</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0601023ACAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Saxagliptin 2.5mg tablets : 24</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020T0&amp;denomIds=3.1.2&amp;selectedTab=summary">Umeclidinium bromide</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>117</td>
      <td>Antimuscarinic bronchodilators</td>
      <td>194</td>
      <td>0.60</td>
      <td>0.12</td>
      <td>0.13</td>
      <td>3.72</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020T0BBAAAA&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Incruse Ellipta 55micrograms/dose dry powder inhaler : 100</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020T0AAAAAA&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Umeclidinium bromide 65micrograms/dose dry powder inhaler : 17</a></div></td></tr></tbody></table>

        <h2>Prescribing where Shirehampton Group Practice is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020Q0&amp;denomIds=3.1.2&amp;selectedTab=summary">Tiotropium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>52</td>
      <td>Antimuscarinic bronchodilators</td>
      <td>194</td>
      <td>0.27</td>
      <td>0.71</td>
      <td>0.18</td>
      <td>-2.42</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020Q0BBADAE&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln refill cart : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020Q0AAACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium brom 2.5microg/dose soln for inhalation CFCfree : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020Q0AAABAB&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 18microgram inhalation powder capsules : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020Q0BBAAAA&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva 18microgram inhalation pdr caps with HandiHaler : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020Q0AAAEAE&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 2.5micrograms/dose inhalation soln cart : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020Q0BBACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln : 24</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0301020Q0BBABAB&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva 18microgram inhalation powder capsules : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0&amp;denomIds=3.2&amp;selectedTab=summary">Beclometasone dipropionate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>385</td>
      <td>Corticosteroids (respiratory)</td>
      <td>1177</td>
      <td>0.33</td>
      <td>0.57</td>
      <td>0.12</td>
      <td>-2.04</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BJAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 50 inhaler : 45</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BPAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 50micrograms/dose inhaler : 59</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BPABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 100micrograms/dose inhaler : 81</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BQAABX&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair 100micrograms/dose / 6micrograms/dose inhaler : 91</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BQABBZ&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair 200micrograms/dose / 6micrograms/dose inhaler : 36</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BRABCA&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair NEXThaler 200microg/dose / 6microg/dose dry pdr inh : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0AABHBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100mcg/dose breath actuated inhaler CFC free : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BJADBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100 Autohaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BJAEBG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 50micrograms/dose Easi-Breathe inhaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0AACACA&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 200microg/Formoterol 6microg/dose dry pdr inh : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BPACBV&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 200micrograms/dose inhaler : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BNAABU&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Easyhaler Beclometasone 200micrograms/dose dry pdr inhaler : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BPADBW&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 250micrograms/dose inhaler : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BTACBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Soprobec 100micrograms/dose inhaler : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BRAABY&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair NEXThaler 100microg/dose / 6microg/dose dry pdr inh : 16</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0BJABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100 inhaler : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0AABEBE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 50micrograms/dose inhaler CFC free : 10</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0AABFBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100micrograms/dose inhaler CFC free : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0302000C0AABXBX&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100microg/Formoterol 6microg/dose inh CFCfree : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=1001022K0&amp;denomIds=10.1.2&amp;selectedTab=summary">Methylprednisolone acetate</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Local corticosteroid injections</td>
      <td>49</td>
      <td>0.06</td>
      <td>0.73</td>
      <td>0.39</td>
      <td>-1.71</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=1001022K0BBAAAA&amp;denomIds=10.1.2&amp;selectedTab=summary" target="_blank">Depo-Medrone 40mg/1ml suspension for injection vials : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=1001022K0BBAEAE&amp;denomIds=10.1.2&amp;selectedTab=summary" target="_blank">Depo-Medrone 120mg/3ml suspension for injection vials : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=1106000AI&amp;denomIds=11.6&amp;selectedTab=summary">Timolol and bimatoprost</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>7</td>
      <td>Treatment of glaucoma</td>
      <td>541</td>
      <td>0.01</td>
      <td>0.10</td>
      <td>0.05</td>
      <td>-1.67</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=1106000AIBBAAAA&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Ganfort 0.3mg/ml / 5mg/ml eye drops : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=1106000AIAAAAAA&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L81008&amp;numIds=0501040H0&amp;denomIds=5.1.4&amp;selectedTab=summary">Gentamicin sulfate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Aminoglycosides</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.72</td>
      <td>0.44</td>
      <td>-1.65</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>